You are here: Industry Insights > kaleo

News List

Marathon Asset Management to acquire pharmaceutical firm Kaléo for $310m Pharmaceutical-Technology
December 01, 2021
Marathon Asset Management has entered a definitive agreement to acquire US-based pharmaceutical firm Kaléo in a deal valued at $310m in cash.
In cybersquatting lawsuit, Adamis says rival Kaléo co-opted its Symjepi trademark fiercepharma
July 04, 2019
Here's one way to fend off new competition—albeit a potentially illegal one.
Kaleo under fire for price hikes on naloxone treatment biopharmadive
November 22, 2018
A Senate report released Sunday heightened scrutiny of a pricing and prescribing strategy used by Kaleo to hike the price of its opioid overdose reversal autoinjector more than 600% in less than three years.
Walgreens and kaléo to offer Auvi-Q shots amid EpiPen shortage September 11, 2018
Walgreens, a drugstore chain in the US, has partnered with pharmaceutical company kaléo to offer increased access to an alternative epinephrine auto-injector called AUVI-Q in response to the continuing EpiPen shortage.
As EpiPens run short, Kaléo boasts it has an available supply of epinephrine injectors fiercepharma
August 16, 2018
Spot shortages persist for Mylan’s lifesaving EpiPens and the epinephrine injectors of some of its rivals, but Kaléo is making sure the public knows its version is available. You just can’t run to your pharmacy and expect to get a box.